Peer Reviewed Publications
Blakeley J, Portnow J. Microdialysis for assessing intratumoral drug disposition in brain cancers: A tool for rational drug development. Expert Opin Drug Metab Toxicol 2010;6(12):1477-91.
Portnow J, Badie B, Chen M, Liu A, Blanchard S, Synold TW. The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: Potential implications for the current approach to chemoradiation. Clin Cancer Res 2009;15(22):7092-98.
Munoz C, Juarez G, Munoz ML, Portnow J, Fineman I, Badie B, Mamelak A, Ferrell B. The quality of life of patients with malignant gliomas and their caregivers. Soc Work in Health Care 2008;47(4):455-78.
Portnow J, Lim C, Grossman SA. Assessment of pain caused by invasive procedures in cancer patients. J Natl Compr Canc Netw 2003;1(3):435-9.
Portnow J, Suleman S, Grossman SA, Eller S, Carson K. A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas. Neuro Oncol 2002;4(1):22-5.
Portnow J. Treatment of primary CNS lymphoma – which one is best? Amer J Oncol Rev 3 2004;(5):286-9.
Co-Principal Investigator, California Institute for Regenerative Medicine (CIRM) Grant DR1-01421, "Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials," Aboody, P.I.
Co-Principal Investigator, NIH Research Grant 1R21CA137639-01A1, "A Pilot Study of 5-FC and Geneticially-Modified Neural Stem Cells to Treat Gliomas," Aboody, Co-P.I.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 03/11.